Product Description: Sofituzumab (MMUC 1206A) is a humanizedized anti-MUC16 recombinant V-kappa antibody[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]El Bairi K, et al. Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer. Semin Cancer Biol. 2021 Dec;77:42-55.